Form 4: Organon & Co. Executive Kirke Weaver Reports Transaction

Kirke Weaver, General Counsel & Corporate Secretary of Organon & Co., reports the acquisition of 8,045 shares of common stock at $9.205 per share on May 6, 2025.

Summary

• On May 6, 2025, Kirke Weaver, the General Counsel & Corporate Secretary of Organon & Co., acquired 8,045 shares of Organon & Co. common stock.
• The shares were purchased at a price of $9.205 per share.
• Following the transaction, Weaver directly owns 52,489 shares of Organon & Co.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. The purchase could be seen as slightly positive, but without more context, it's difficult to assess the overall impact.

Positives

• An officer purchasing shares may signal confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities. These filings are closely watched by investors seeking insights into management's perspective on the company's value.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Organon & Co., Kirke Weaver, Form 4, insider trading, stock acquisition, OGN, General Counsel, Corporate Secretary